Cell and Gene Therapy for Rare & Common Diseases


Gene Therapy is used to treat inherited Muscular disordercardiovascular disorder, HIV, cancer etc. In stem cell transplants, stem cells replace cells damaged by chemotherapy or disease or as a way for the donor's immune system to provoke immunity against some types of cancer and blood-related diseases, such as leukaemia. Cellular Therapy is internationally recognized for its novel approaches in treating blood related disorders like leukaemia, lymphoma, myeloma, and other life-threatening diseases. The stem cell transplantation of hematopoietic stem cells (HSCT) in which the allogeneic hematopoietic stem cells are harvested from healthy donors of same species and autologous stem cell from the patient itself. Both therapies use high dosage cytotoxic medication in order to induce higher remission rates against malignant diseases. Autologous HSCT preferably used in relapsed malignant high-grade lymphoma and Allogeneic HSCT preferred for therapeutic effect against acute leukaemia with unfavourable prognosis in a high percentage of patients. The Recent developments based on the expansion of the donor pool for allogeneic stem cells in order to reduce dosage as well as chemotherapeutic toxicity of allogeneic transplantation with sustainable anti-leukaemia efficacy.


    Related Conference of Cell and Gene Therapy for Rare & Common Diseases

    November 21-22, 2024

    11th World Congress on Epigenetics and Chromosome

    Dubai, UAE
    December 09-10, 2024

    17th World Congress on Stem Cell Research

    Dubai, UAE
    March 17-18, 2025

    8th Global Conference on Cell and Gene Therapy

    Paris, France
    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany

    Cell and Gene Therapy for Rare & Common Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in